Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects (full – 2009)

Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling (full – 2009)

Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons (full – 2009)

Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full – 2011)

Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum (full – 2011)

Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation (full – 2011)

Inhibition of monoacylglycerol lipase (MAGL) attenuates NSAID-induced gastric hemorrhages in mice (full – 2011)

Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat (full – 2012)

Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease (full – 2012)

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model (abst – 2013)

Study: Cannabinoids Offer Treatment For Severe Lung Disease (news – 2013)
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full – 2013)

Dynamic changes to the endocannabinoid system in models of chronic pain (full – 2012)http://rstb.royalsocietypublishing.o...f-857201f5e069

The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full – 2013)

Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Anti-Withdrawal Effects in Morphine-Dependent Mice (full – 2013)

Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full – 2013)

Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst – 2013)

The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst – 2013)

Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014)

The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells (full – 2014)

Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice (full – 2014)

Monoacylglycerol Lipase Inhibition Blocks Chronic Stress-Induced Depressive-Like Behaviors via Activation of mTOR Signaling (abst – 2014)

Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (abst – 2014)

Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats (abst – 2014)

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents (abst – 2014)

Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst – 2014)

The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184 (abst – 2014)

Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase (abst – 2014)

The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model (abst – 2014)

Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey (abst – 2014)